Applied Therapeutics, Inc.
APLT
Revenue
144.00k
▼-46.00k▼-24.21%
3 Months ChangeAssets
127.78M
▼-23.46M▼-15.51%
3 Months ChangeLiabilities
55.39M
▼-28.55M▼-34.02%
3 Months ChangeFree Cash Flow
0.00
0.000.00%
-Revenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-08-07
Form 10-Q
ID: 0001558370-24-011200
2024-08-07
Form 8-K
ID: 0001104659-24-086532
2024-06-06
Form 8-K
ID: 0001104659-24-069110
2024-05-09
Form 10-Q
ID: 0001558370-24-007465
2024-05-09
Form 8-K
ID: 0001104659-24-059107
2024-04-15
Form 8-K
ID: 0001104659-24-047334
2024-03-29
Form 8-K
ID: 0001104659-24-040664
2024-03-11
Form 8-K
ID: 0001104659-24-032733
2024-03-06
Form 8-K
ID: 0001104659-24-031273
2024-02-29
Form 8-K
ID: 0001104659-24-029384